More on PFE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1.9% Growth)
- Ratings (6.1 Score)
- Holders
- Dividends (3.7% Yield)
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (4/27/16 *Est.)
- Analyst Day (5/3/2016)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

PFE Income Statement

Click line-items for a historical chart and %
Revenues
Costs and expenses:
Cost of sales
Selling, informational and administrative expenses 5.05B
Research and development expenses 2.35B
Amortization of intangible assets
Acquisition-related in-process research and development charges
Restructuring charges and certain acquisition-related costs 425M
Other deductions--net
Income from continuing operations before provision for taxes on income -353M
Provision for taxes on income -188M
Income from continuing operations -166M
Discontinued operations:
Income from operations--net of tax
Gain on sale of discontinued operations--net of tax
Discontinued operations--net of tax -3M
Net income before allocation to noncontrolling interests -169M
Less: Net income attributable to noncontrolling interests 2M
Net income attributable to Pfizer Inc. -172M
Earnings per share--basic:
Income from continuing operations attributable to Pfizer Inc. common shareholders -0.02
Discontinued operations--net of tax (in dollars per share) 0
Net income attributable to Pfizer Inc. common shareholders (in dollars per share) -0.03
Earnings per share--diluted:
Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) -0.03
Discontinued operations--net of tax (in dollars per share) 0
Net income attributable to Pfizer Inc. common shareholders (in dollars per share) -0.03
Weighted-average shares used to calculate earnings per common share:
Basic (in shares) -12.35B
Diluted (in shares) -12.52B
Cash dividends paid per common share (in dollars per share) 0.28